undefined

Chuck Aoki

American Paralympic wheelchair rugby player representing Team USA in his fourth Paralympics. Provides insights into wheelchair rugby, the Paralympic classification system, and the growing interest in the Paralympics.

Top 3 podcasts with Chuck Aoki

Ranked by the Snipd community
undefined
Dec 31, 2024 • 24min

Wheelchair rugby’s Chuck Aoki makes us smart about the Paralympics (rerun)

Chuck Aoki, an inspiring Paralympic wheelchair rugby player and veteran of four games, shares fascinating insights about the upcoming Paralympics in Paris. He delves into the thrilling world of wheelchair rugby, aka "murderball," and discusses how athletes are classified based on disability. Aoki also highlights the surge in interest due to live broadcasts and social media, elevating visibility for Paralympians. The conversation touches on how this year’s games promise to reach a larger audience than ever before.
undefined
Dec 31, 2024 • 24min

Wheelchair rugby’s Chuck Aoki makes us smart about the Paralympics (rerun)

Chuck Aoki, an accomplished American Paralympic wheelchair rugby player and a seasoned competitor for Team USA, shares his passion for 'murderball' as he prepares for his fourth Paralympics. He unpacks the classification system for athletes, shedding light on how it empowers and recognizes diverse abilities. Aoki also discusses the increasing buzz around the upcoming Paralympics in Paris, driven by enhanced media coverage and social media awareness. This year promises to reach unprecedented viewership—exciting times for adaptive sports!
undefined
Aug 28, 2024 • 26min

Wheelchair rugby’s Chuck Aoki makes us smart about the Paralympics

Chuck Aoki, an accomplished American Paralympic wheelchair rugby player, brings thrilling insights just ahead of the Paris Paralympics. He discusses the excitement surrounding adaptive sports and how wheelchair rugby, known as ‘murderball,’ operates under a unique classification system. Aoki emphasizes the growing visibility of the Paralympics, driven by live broadcasts and social media. The conversation also touches on healthcare innovations, specifically the impact of direct-to-consumer programs by pharmaceutical companies on drug pricing.